HIGHLIGHTS
- What: The current randomized controlled trial aims to assess the efficacy of HD-tDCS as an augmentation therapy with antidepressants compared to sham-control in subjects of MDD with ADS. From the pilot study Advantages of a new format of tDCS: HD‑tDCS This study proposes a RCT with parallel group design, in which participants are randomly allocated to the experimental group or the sham group in a 1:1 ratio. The group will meet on a monthly basis to assess progress and ensure that the study is being conducted in accordance with the requirements of research . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.